Alexander Marcus Seifalian, Professor of Nanotechnology worked at the University College London for over 26 years, during this time he spent a year at Harvard University and a year at Johns Hopkins Medical School. His scientific training at London University, KCL and UCL, was in Physics, Chemistry, and Biotechnology. He published more than 647 peer-reviewed research papers and registered 14 UK and International patents. He is currently CEO of NanoRegMed Ltd, working on the commercialization of his research.
In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment. He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Recently Alexander has licensed a family of novel functionalized graphene oxide and synthetic graphene-based nanocomposite materials for industrial application and has currently been working on the commercialization of his graphene-based nanocomposite materials for the aerospace and automotive industries.